Advisor Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.37M | Buy |
27,359
+3,649
| +15% | +$194K | 0.1% | 218 |
|
|
2022
Q1 | $1.22M | Buy |
23,710
+381
| +2% | +$19.7K | 0.08% | 255 |
|
|
2021
Q4 | $1.17M | Buy |
23,329
+414
| +2% | +$20.5K | 0.07% | 269 |
|
|
2021
Q3 | $1.1M | Buy |
22,915
+693
| +3% | +$35.2K | 0.07% | 252 |
|
|
2021
Q2 | $1.17M | Buy |
22,222
+888
| +4% | +$46.3K | 0.08% | 251 |
|
|
2021
Q1 | $1.05M | Buy |
21,334
+289
| +1% | +$13.9K | 0.08% | 259 |
|
|
2020
Q4 | $1.02M | Sell |
21,045
-5,662
| -21% | -$279K | 0.08% | 245 |
|
|
2020
Q3 | $1.34M | Buy |
26,707
+3,334
| +14% | +$172K | 0.12% | 164 |
|
|
2020
Q2 | $1.19M | Buy |
23,373
+7,168
| +44% | +$348K | 0.11% | 176 |
|
|
2020
Q1 | $709K | Buy |
16,205
+4,019
| +33% | +$192K | 0.09% | 215 |
|
|
2019
Q4 | $624K | Buy |
12,186
+2,854
| +31% | +$134K | 0.06% | 297 |
|
|
2019
Q3 | $432K | Buy |
9,332
+1,392
| +18% | +$60K | 0.05% | 364 |
|
|
2019
Q2 | $344K | Sell |
7,940
-912
| -10% | -$38.8K | 0.04% | 418 |
|
|
2019
Q1 | $392K | Sell |
8,852
-4,548
| -34% | -$195K | 0.05% | 359 |
|
|
2018
Q4 | $582K | Buy |
13,400
+3,554
| +36% | +$157K | 0.09% | 236 |
|
|
2018
Q3 | $440K | Buy |
9,846
+3,343
| +51% | +$143K | 0.06% | 338 |
|
|
2018
Q2 | $260K | Buy |
6,503
+1,245
| +24% | +$49K | 0.04% | 456 |
|
|
2018
Q1 | $211K | Buy |
+5,258
| New | +$219K | 0.04% | 517 |
|
|
2017
Q1 | – | Sell |
-5,176
| Closed | -$209K | – | 447 |
|
|
2016
Q4 | $209K | Buy |
+5,176
| New | +$204K | 0.06% | 382 |
|
|
2016
Q1 | – | Sell |
-6,770
| Closed | -$289K | – | 403 |
|
|
2015
Q4 | $289K | Buy |
6,770
+280
| +4% | +$12.9K | 0.1% | 219 |
|
|
2015
Q3 | $308K | Sell |
6,490
-203
| -3% | -$10.3K | 0.13% | 193 |
|
|
2015
Q2 | $331K | Buy |
6,693
+1,258
| +23% | +$63.8K | 0.13% | 206 |
|
|
2015
Q1 | $269K | Sell |
5,435
-153
| -3% | -$7.32K | 0.11% | 240 |
|
|
2014
Q4 | $258K | Sell |
5,588
-470
| -8% | -$22.8K | 0.11% | 231 |
|
|
2014
Q3 | $342K | Buy |
6,058
+184
| +3% | +$9.88K | 0.2% | 146 |
|
|
2014
Q2 | $312K | Buy |
5,874
+171
| +3% | +$9.08K | 0.15% | 181 |
|
|
2014
Q1 | $298K | Sell |
5,703
-36
| -0.6% | -$1.82K | 0.16% | 179 |
|
|
2013
Q4 | $308K | Buy |
5,739
+246
| +4% | +$12.7K | 0.18% | 170 |
|
|
2013
Q3 | $278K | Buy |
5,493
+346
| +7% | +$17.6K | 0.2% | 161 |
|
|
2013
Q2 | $265K | Buy |
+5,147
| New | +$274K | 0.22% | 146 |
|
Other funds holding SNY
CCM
Advisor Partners's SNY Position: Q2 2022 in Review
Advisor Partners increased its Sanofi (SNY) stake by 15% in Q2 2022, buying an estimated $194K and bringing the position to 27,359 shares worth $1.37M. The position accounts for 0.1% of the portfolio, ranked #218.
Advisor Partners first reported a position in SNY in Q2 2013 and has held it in 30 quarters since. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.
- Advisor Partners held 27,359 shares of Sanofi worth $1.37M as of Q2 2022.
- Advisor Partners bought 3,649 Sanofi shares in Q2 2022, an estimated $194K.
- Sanofi made up 0.1% of Advisor Partners's portfolio in Q2 2022, its #218 holding.
- Advisor Partners first reported a position in Sanofi in Q2 2013 and has held it in 30 quarters since.
- 656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.